RU2712027C2 - Соединения фенилкетонкарбоксилата и фармацевтические композиции для предотвращения и лечения остеопороза - Google Patents

Соединения фенилкетонкарбоксилата и фармацевтические композиции для предотвращения и лечения остеопороза Download PDF

Info

Publication number
RU2712027C2
RU2712027C2 RU2017116154A RU2017116154A RU2712027C2 RU 2712027 C2 RU2712027 C2 RU 2712027C2 RU 2017116154 A RU2017116154 A RU 2017116154A RU 2017116154 A RU2017116154 A RU 2017116154A RU 2712027 C2 RU2712027 C2 RU 2712027C2
Authority
RU
Russia
Prior art keywords
osteoporosis
use according
compound
bone
cooh
Prior art date
Application number
RU2017116154A
Other languages
English (en)
Russian (ru)
Other versions
RU2017116154A (ru
RU2017116154A3 (enExample
Inventor
Лин Ганьон
Брижит Груа
Original Assignee
Лиминал Байосайенсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лиминал Байосайенсиз Лимитед filed Critical Лиминал Байосайенсиз Лимитед
Publication of RU2017116154A publication Critical patent/RU2017116154A/ru
Publication of RU2017116154A3 publication Critical patent/RU2017116154A3/ru
Application granted granted Critical
Publication of RU2712027C2 publication Critical patent/RU2712027C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2017116154A 2014-10-10 2015-10-08 Соединения фенилкетонкарбоксилата и фармацевтические композиции для предотвращения и лечения остеопороза RU2712027C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462062660P 2014-10-10 2014-10-10
US62/062,660 2014-10-10
PCT/CA2015/000530 WO2016054725A1 (en) 2014-10-10 2015-10-08 Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

Publications (3)

Publication Number Publication Date
RU2017116154A RU2017116154A (ru) 2018-11-12
RU2017116154A3 RU2017116154A3 (enExample) 2019-05-06
RU2712027C2 true RU2712027C2 (ru) 2020-01-27

Family

ID=55652426

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017116154A RU2712027C2 (ru) 2014-10-10 2015-10-08 Соединения фенилкетонкарбоксилата и фармацевтические композиции для предотвращения и лечения остеопороза

Country Status (22)

Country Link
US (1) US10925846B2 (enExample)
EP (1) EP3204000B1 (enExample)
JP (1) JP6700638B2 (enExample)
KR (1) KR20170066613A (enExample)
CN (1) CN106999459B (enExample)
AR (1) AR102247A1 (enExample)
AU (1) AU2015330642B2 (enExample)
BR (1) BR112017007386A2 (enExample)
CA (1) CA2963358C (enExample)
DK (1) DK3204000T3 (enExample)
ES (1) ES2794782T3 (enExample)
IL (1) IL251409B (enExample)
MX (1) MX376880B (enExample)
MY (1) MY187511A (enExample)
PH (1) PH12017500636A1 (enExample)
PL (1) PL3204000T3 (enExample)
PT (1) PT3204000T (enExample)
RU (1) RU2712027C2 (enExample)
SG (1) SG11201702810TA (enExample)
TW (1) TWI723962B (enExample)
UY (1) UY36355A (enExample)
WO (1) WO2016054725A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3203999T3 (pl) * 2014-10-10 2020-07-27 Liminal Biosciences Limited Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006124662A1 (en) * 2005-05-13 2006-11-23 Synta Pharmaceuticals Corp. Il-12 modulatory compounds
WO2012055014A1 (en) * 2010-10-27 2012-05-03 Prometic Biosciences Inc. Phenylketone carboxylate compounds and pharmaceutical uses thereof
WO2012097428A1 (en) * 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and pharmaceutical compositions for uses in diabetes
WO2012097427A1 (en) * 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and compositions for the treatment of cancer
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2777629C (en) * 2009-10-14 2018-02-13 The Governors Of The University Of Alberta Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
PL3203999T3 (pl) * 2014-10-10 2020-07-27 Liminal Biosciences Limited Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006124662A1 (en) * 2005-05-13 2006-11-23 Synta Pharmaceuticals Corp. Il-12 modulatory compounds
WO2012055014A1 (en) * 2010-10-27 2012-05-03 Prometic Biosciences Inc. Phenylketone carboxylate compounds and pharmaceutical uses thereof
WO2012097428A1 (en) * 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and pharmaceutical compositions for uses in diabetes
WO2012097427A1 (en) * 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and compositions for the treatment of cancer
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CELSO MARTINS QUEIROZ-JUNIOR et al. A Controversial role for IL-12 in immune response and bone resorption at apical periodontal sites. Clinical and developmental immunology. Vol. 2010 Accepted 22.12.2010, реферат, фиг.1. *
WANG Yue et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. Phytomedicine. 20 (2013) 787-796, с.790, глава Результаты, с.793, 2 колонка. *
ШОСТАК Н.А. и др. Ревматоидный артрит и остеопороз. РМЖ N5 от 06.03.2004 с.287 [онлайн] [найдено 25.04.2019] (найдено из интернет: www.rmj.ru). *

Also Published As

Publication number Publication date
CA2963358A1 (en) 2016-04-14
TW201618761A (zh) 2016-06-01
SG11201702810TA (en) 2017-05-30
IL251409B (en) 2020-08-31
UY36355A (es) 2016-06-01
CN106999459B (zh) 2020-07-10
PT3204000T (pt) 2020-05-06
RU2017116154A (ru) 2018-11-12
AU2015330642A1 (en) 2017-05-11
BR112017007386A2 (pt) 2018-01-23
PH12017500636A1 (en) 2017-09-25
ES2794782T3 (es) 2020-11-19
CN106999459A (zh) 2017-08-01
EP3204000B1 (en) 2020-01-08
TWI723962B (zh) 2021-04-11
DK3204000T3 (da) 2020-04-06
WO2016054725A1 (en) 2016-04-14
IL251409A0 (en) 2017-05-29
EP3204000A1 (en) 2017-08-16
AR102247A1 (es) 2017-02-15
JP6700638B2 (ja) 2020-05-27
US20190038580A1 (en) 2019-02-07
CA2963358C (en) 2023-03-07
MX376880B (es) 2025-03-07
PL3204000T3 (pl) 2020-07-27
KR20170066613A (ko) 2017-06-14
JP2017530179A (ja) 2017-10-12
MY187511A (en) 2021-09-24
US10925846B2 (en) 2021-02-23
AU2015330642B2 (en) 2019-07-04
EP3204000A4 (en) 2018-06-20
RU2017116154A3 (enExample) 2019-05-06
MX2017004735A (es) 2017-11-17

Similar Documents

Publication Publication Date Title
US11185521B2 (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
EP2970089B1 (en) Substituted aromatic compounds
BR112020013694A2 (pt) derivados de ácido 3-fenil-4-hexinôico como agonistas gpr40
EA022988B1 (ru) Соединения фенилкетонкарбоксилата и их фармацевтическое применение
CA2963358C (en) Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
HK1236419A1 (en) Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
HK1236419B (en) Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
TW201728332A (zh) 新穎雙膦酸化合物
HK1236420A1 (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
HK1236420B (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
JP2005035895A (ja) 高カルシウム血症および骨疾患治療剤
JP2025539852A (ja) ４（ｒｓ）－４－ｆ４－ニューロプロスタン誘導体（４－ｆ４ｔ－ｎｅｕｒｏｐ）並びに人工呼吸器誘発性横隔膜機能不全及び他の疾患の処置におけるそれらの使用
TW201406380A (zh) 次發性副甲狀腺機能亢進症治療劑

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner